JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Home・Aktien・Pulmatrix Inc

Pulmatrix Inc

Geschlossen

1.27 3.25

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.24

Max

1.27

Schlüsselkennzahlen
By Trading Economics
Einkommen	-51K -928K
EPS	-0.254
Angestellte	2
EBITDA	-51K -928K

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-6.5M 4.9M
Vorheriger Eröffnungskurs	-1.98
Vorheriger Schlusskurs	1.27

Pulmatrix Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Mai 2026, 21:36 UTC

Akquisitionen, Fusionen, Übernahmen

FTC Requires 365 Retail Markets to Divest Micromarket Kiosk Business to Clear Acquisition of Cantaloupe

1. Mai 2026, 20:40 UTC

Akquisitionen, Fusionen, Übernahmen

Meta Platforms Acquires Humanoid Robot Startup Assured Robot Intelligence

1. Mai 2026, 18:37 UTC

Wichtige Markttreiber

Senseonic Shares Slide on Underwritten Offering Price

1. Mai 2026, 16:46 UTC

Wichtige Markttreiber

Stellantis, Ferrari Fall on Trump Plan to Increase Tariff on European Cars, Trucks

2. Mai 2026, 19:57 UTC

Akquisitionen, Fusionen, Übernahmen

Berkshire CEO Greg Abel Takes the Stage, Making a Case for the Post-Buffett Era -- 3rd Update

2. Mai 2026, 15:24 UTC

Ergebnisse

Berkshire CEO Greg Abel Takes the Stage, Talks Through Quarterly Results -- Update

2. Mai 2026, 12:46 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Berkshire Profits More Than Double on Gains in Insurance, Railroad, Energy Businesses -- WSJ

2. Mai 2026, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

1. Mai 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

1. Mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

1. Mai 2026, 20:42 UTC

Ergebnisse

Western Digital Beats Earnings Estimates. The Stock Is Falling Anyway. -- Barrons.com

1. Mai 2026, 19:33 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1. Mai 2026, 19:33 UTC

Market Talk

Change in Fed Leadership May Hamper Crypto Rebound -- Market Talk

1. Mai 2026, 19:18 UTC

Market Talk

Wichtige Nachrichtenereignisse

Oil Rises for Second Consecutive Week Amid Middle East Standoff -- Market Talk

1. Mai 2026, 19:13 UTC

Market Talk

Natural Gas Rises as Markets Wait for Warmer Temperatures -- Market Talk

1. Mai 2026, 18:36 UTC

Ergebnisse

3 Takeaways From Apple Earnings. The Stock Is Surging. -- Barrons.com

1. Mai 2026, 18:35 UTC

Ergebnisse

Moderna's Covid Vaccine Is Driving Growth Again. The Stock Is Down Anyway. -- Barrons.com

1. Mai 2026, 18:28 UTC

Ergebnisse

These Stocks Are Today's Movers: Apple, Sandisk, Roblox, Intel, Ferrari, Atlassian, Western Digital, Clorox, Paramount Skydance, and More -- Barrons.com

1. Mai 2026, 18:27 UTC

Market Talk

Gold and Silver Higher for the Day, Lower For The Week -- Market Talk

1. Mai 2026, 18:14 UTC

Akquisitionen, Fusionen, Übernahmen

Barclays Completes Acquisition of Best Egg

1. Mai 2026, 18:04 UTC

Ergebnisse

The First $6 Trillion Company May Not Be Nvidia -- Barrons.com

1. Mai 2026, 17:43 UTC

Market Talk

Home Sales in San Francisco Jump 22.2% in March -- Market Talk

1. Mai 2026, 17:37 UTC

Market Talk

Crypto 'Fear and Greed Index' Returns to Neutral Reading After Brief Dip -- Market Talk

1. Mai 2026, 17:30 UTC

Market Talk

Ergebnisse

Apple's 2Q Print, 3Q Guide Set Up Stock to Outperform -- Market Talk

1. Mai 2026, 17:28 UTC

Market Talk

Ergebnisse

Apple's Shift From Net Cash Neutral Goal Seen as Cryptic Signal -- Market Talk

1. Mai 2026, 17:21 UTC

Market Talk

Ergebnisse

Apple Seen Absorbing Higher Memory Costs -- Market Talk

1. Mai 2026, 17:19 UTC

Market Talk

Wichtige Nachrichtenereignisse

U.S. Oil Rig Count Rises by 1 to 408 -- Market Talk

1. Mai 2026, 16:38 UTC

Market Talk

Institutional Markets Begin to Trade on Event Contracts -- Market Talk

1. Mai 2026, 16:23 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Skydance Gets a Double Upgrade. It's the Warner Bros. Deal. -- Barrons.com

1. Mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Pulmatrix Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Pulmatrix Inc – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Pulmatrix Inc

Pulmatrix, Inc., a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates. The company was founded in 2003 and is headquartered in Bedford, Massachusetts.